July 9, 2018 Environ, Ag./Food & Bev Lab Top-10 PR/Corporate

AOAC Method of the Year for Confirmation and Identification in Food Microbiology Awarded to MALDI Biotyper® OMA

– MALDI Biotyper certified by MicroVal for fast and reliable routine confirmation of foodborne pathogenic bacteria under ISO/DIS 16140-6 SALT LAKE CITY, July 9, 2018 /PRNewswire/ — At the 2018 Annual Meeting of the International Association of Food Protection (www.foodprotection.org/), Bruker announces a standardized workflow for any microbial isolate confirmation and identification in food microbiology. The... Read more

July 3, 2018 PR/Corporate

Brooks Automation to Participate in the CEO Investor Summit 2018

CHELMSFORD, Mass., July 3, 2018 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced today that the Company’s management will participate in the 10th Annual CEO Investor Summit 2018, on Wednesday, July 11, 2018 in San Francisco, California. About The CEO Investor Summit The CEO Summit is an accredited investor and publishing research analyst event that is... Read more

July 2, 2018 Atomic Spectroscopy PR/Corporate Product Launch

Rigaku Presents Latest X-ray Diffraction Instrumentation at EPDIC16

Rigaku is a Gold Sponsor of the 16th European Powder Diffraction Conference (EPDIC16), being held in Edinburgh from 1st – 4th July 2018. July 2, 2016 –Edinburgh, Scotland. Rigaku Corporation is pleased to announce its attendance at The 16th European Powder Diffraction Conference (EPDIC16) taking place at the John McIntyre Conference Centre, Edinburgh University. Established in... Read more

July 2, 2018 Life Science Tools PR/Corporate

Life Sciences Industry Veteran Todd R. Nelson Named SGI-DNA CEO to Lead Spin-out from Synthetic Genomics

LA JOLLA, CA — July 2, 2018 —SGI-DNA, a leader in commercial DNA synthesis, today announced industry veteran Todd R. Nelson, Ph.D., MBA has been appointed Chief Executive Officer to lead the spin-out of the company from Synthetic Genomics, Inc. (SGI). “Todd is a proven life sciences leader who brings a wealth of knowledge and experience... Read more

July 2, 2018 Bio/Pharma/CRO Licensing, IP, and Legal PR/Corporate

Phase III IMpassion130 study showed Roche’s Tecentriq plus Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer

Basel, 02 July 2018 Phase III IMpassion130 study showed Roche’s Tecentriq plus Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer First Phase III immunotherapy study to demonstrate a statistically significant improvement in progression-free survival (PFS) in the intention-to-treat (ITT) and PD-L1 positive first-line metastatic triple... Read more

June 28, 2018 Bio/Pharma/CRO M&A, Partnerships PR/Corporate

Agilent Technologies to Expand Biopharma Consumables Portfolio with Acquisition of ProZyme

Highlights: Highly synergistic with Agilent’s current customer-base and sales channel Enables complete LC and LC/MS workflow solutions in important glycan biopharma segment Strengthens Agilent’s customer value proposition in fast-growing biopharma market SANTA CLARA, Calif.–(BUSINESS WIRE)–Jun. 28, 2018– Agilent Technologies Inc. (NYSE: A) today announced that it has entered into a definitive agreement to acquire privately-held ProZyme,... Read more

June 28, 2018 Bio/Pharma/CRO M&A, Partnerships PR/Corporate

Agilent Technologies to Expand Biopharma Consumables Portfolio with Acquisition of ProZyme

Highlights: Highly synergistic with Agilent’s current customer-base and sales channel Enables complete LC and LC/MS workflow solutions in important glycan biopharma segment Strengthens Agilent’s customer value proposition in fast-growing biopharma market SANTA CLARA, Calif.–(BUSINESS WIRE)–Jun. 28, 2018– Agilent Technologies Inc. (NYSE: A) today announced that it has entered into a definitive agreement to acquire privately-held ProZyme,... Read more

June 28, 2018 Bio/Pharma/CRO M&A, Partnerships PR/Corporate

Agilent Technologies to Expand Biopharma Consumables Portfolio with Acquisition of ProZyme

Highlights: Highly synergistic with Agilent’s current customer-base and sales channel Enables complete LC and LC/MS workflow solutions in important glycan biopharma segment Strengthens Agilent’s customer value proposition in fast-growing biopharma market SANTA CLARA, Calif.–(BUSINESS WIRE)–Jun. 28, 2018– Agilent Technologies Inc. (NYSE: A) today announced that it has entered into a definitive agreement to acquire privately-held ProZyme,... Read more

June 26, 2018 Cell Analysis Tools Life Science Tools PR/Corporate

David King Joins Fluidigm as Vice President, Research and Development, Genomics

SOUTH SAN FRANCISCO, Calif., June 26, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of David King as Vice President, Research and Development, Genomics. As a member of the executive leadership team reporting to President and CEO Chris Linthwaite, King will drive R&D strategy and execution for all genomics products and systems across the company. “Fluidigm is a leader... Read more

June 22, 2018 Acad, Gov/Utilities PR/Corporate

2018 Eppendorf Award for Young European Investigators presented to Andrea Ablasser

06/22, 2018 This year’s research prize awarded by Eppendorf AG goes to Switzerland Heidelberg/Hamburg, June 22, 2018 In 2018, the Hamburg life science company is presenting its highly prestigious research prize for the 23rd time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Andrea Ablasser, Assistant Professor at the Swiss... Read more